Back to results
US 2007/0185041 A1Published application
Novel 3-triazolyl-galactoside inhibitors of galectins
AssigneeForskarpatent I Syd AB
InventorsHakon Leffler, Bader Salameh, Ulf Nilsson
Life of this patent
Estimating the term…
Abstract
The present invention relates to novel compounds, the use of said compounds as a medicament as well as for the manufacture of a medicament for treatment of disorders relating to the binding of galectin to receptors in a mammal. Said galectin is preferably a galectin-3.
Claims19
A compound of the general formula (I):
- wherein
- the configuration of the pyranose ring is D-galacto;
- X is selected from the group consisting of O, S, NH, CH2, and NR4, or is a bond;
- Y is selected from the group consisting of CH2, CO, SO2, SO, PO2 and PO, phenyl, or is a bond;
- R1 is selected from the group consisting of;
- a) a saccharide;
- b) a substituted saccharide;
- c) D-galactose;
- d) substituted D-galactose;
- e) C3-[1,2,3]-triazol-1-yl-substituted D-galactose;
- f) hydrogen, an alkyl group, an alkenyl group, an aryl group, a heteroaryl group, and a heterocycle and derivatives thereof;
- g) an amino group, a substituted amino group, an imino group, or a substituted imino group.
- R2 is selected from the group consisting of;
- hydrogen, an amino group, a substituted amino group, an alkyl group, a substituted alkyl group, an alkenyl group, a substituted alkenyl group, an alkynyl group, a substituted alkynyl group, an alkoxy group, a substituted alkoxy group, an alkylamino group, a substituted alkylamino group, an arylamino group, a substituted arylamino group, an aryloxy group, a substituted aryloxy group, an aryl group, a substituted aryl group, a heteroaryl group, a substituted heteroaryl group, and a heterocycle, a substituted heterocycle.
11 more elements
Dependencies are inferred from the claim text.